Health Ministry Bans 16 Fixed Dose Combinations (FDCs)
Examining the regulatory framework under the Drugs and Cosmetics Act, 1940, the role of the DTAB, and the public health rationale behind banning irrational drug combinations.
What happened
Aspirants often focus on flagship health schemes, but the regulatory backbone of public health is equally crucial for Mains. This ban on Fixed Dose Combinations is not a routine administrative update; it's a direct application of statutory power to enforce scientific rationality in medicine. It directly links to GS-2 topics on governance and health, and GS-3 concerns like Antimicrobial Resistance, making it a prime example of evidence-based policymaking in action.
The core of this issue lies in the institutional mechanism for drug regulation in India.
●The ban is not an arbitrary executive decision but a quasi-judicial process rooted in law.
●The power to prohibit drugs in the public interest is granted to the Central Government by Section 26A of the Drugs and Cosmetics Act, 1940.
●Crucially, this power is exercised based on the scientific and technical recommendations of the Drugs Technical Advisory Board (DTAB), the country's highest statutory body on drug-related technical matters.
●Understanding this chain of command—from Expert Committee review to DTAB recommendation to a government notification under Section 26A—is key to grasping how drug safety is enforced in India.
The Central Government's power to ban drugs under Section 26A of the Drugs and Cosmetics Act, 1940, is exercised based on scientific advice from the Drugs Technical Advisory Board (DTAB).
◎ In Simple Words
Imagine a medicine pill is like a recipe. A good recipe combines ingredients that work well together to make a tasty and healthy dish. A Fixed Dose Combination (FDC) is a single pill that mixes two or more medicines. The government has found that 16 of these 'medicine recipes' are not good. The ingredients don't work well together, have no extra benefit, and could even be harmful. So, it has banned them to make sure the medicines available to us are safe and actually help us get better.
Factual Pointers
Practice · 2 questions
Which statutory body is the highest authority in India for advising the Central and State Governments on technical matters arising out of the administration of the Drugs and Cosmetics Act, 1940?
The Central Government's power to regulate, restrict, or prohibit the manufacture and sale of any drug in the public interest is derived from which provision of the Drugs and Cosmetics Act, 1940?
Mains Practice Questions
The recent ban on several Fixed Dose Combinations (FDCs) highlights the persistent tension between public health objectives and pharmaceutical market dynamics in India. Critically analyse the regulatory challenges in ensuring the availability of only rational drug combinations.
While Fixed Dose Combinations (FDCs) can improve patient compliance, their irrational use poses a significant threat, particularly in fueling Antimicrobial Resistance (AMR). Discuss the scientific and administrative measures required to curb this menace.
Evaluate the role of the Drugs Technical Advisory Board (DTAB) and the Central Drugs Standard Control Organisation (CDSCO) in safeguarding public health. Is the current regulatory framework adequate to address the complexities of the modern pharmaceutical industry?